New user? / Forgot your password?
0 Item | 0,00 €
Need NMR solvents or supplies? Click here and check out our ARMAR Isotopes catalog!
Kanamycin monosulfate
| Item number | 674877 |
| CAS | 25389-94-0 |
| Formula | C18H38N4O15S |
| Molecular weight | 582,58 g/mol |
| Quantity | 1X100MG |
| storage conditions | 4 °C |
| CoA / MSDS | Retrieve CoA Retrieve MSDS |
Price | Please log in. |
Product Variations:
Product | Catalog No./ CAS No. | Quantity | Price | |
|---|---|---|---|---|
 | 674877 | 1X100MG | Please log in. |
| Safety Data Sheet | according to Regulation (EC) No 1907/2006 (REACH) Classifications according to Regulation (EC) No 1272/2008. Printdate 15.01.2025 |
| IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING | |
| Product name: | Kanamycin monosulfate |
| Catalog No.: | 674877 |
| Relevant identified uses of the substance or mixture | Identified: Laboratory chemical uses: R&D |
| Uses advised against: | HPC Standards GmbH Am Wieseneck 7 04451 Cunnersdorf Deutschland Tel. +49 34291 3372-36 Fax. +49 34291 3372-39 contact@hpc-standards.com |
| Emergency telephone number | HPC Standards Tel. +49 34291 3372-36 This number is only available during office hours. |
| HAZARDS IDENTIFICATION | 2.1 Classification of the substance or mixture Classification according to Regulation (EC) No 1272/2008 Reproductive toxicity ( Category 1B ), H360 Classification according to EU Directives 67/548/EEC or 1999/45/EC T Toxic R61 |
| Label elements | |
| Pictogram | GHS08 silhouete silhouete |
| 2.2 Label elements Labelling according Regulation (EC) No 1272/2008 Pictogram Signal word Danger Hazard statement(s) H360 May damage fertility or the unborn child. Precautionary statement(s) P201 Obtain special instructions before use. P308 + P313 IF exp osed or concerned: Get medical advice/ attention. Supplemental Hazard Statements none Restricted to professional users. 2.3 Other hazards - none | |
| COMPOSITION/INFORMATION ON INGREDIENTS | 3.1 Substances Synonyms : Kanamycin Kanamycin A Formula : C 18 H 36 N 4 O 11 · H 2 O 4 S Molecular Weight : 582,58 g/mol CAS - No. : 25389 - 94 - 0 EC - No. : 246 - 933 - 9 Hazardous ingredients according to Regulation (EC) No 1272/2008 Component Classification Concentration Kanamycin sulphate CAS - No. EC - No. 25389 - 94 - 0 246 - 933 - 9 Repr. 1B ; H360 <= 100 % Hazardous ingredients according to Directive 1999/45/EC Component Classification Concentration Kanamycin sulphate CAS - No. EC - No. 25389 - 94 - 0 246 - 933 - 9 T , R61 <= 100 % |
| Formula | C18H38N4O15S |
| Molecular Weight (g/mol) | 582.58 |
| CAS-No. | 25389-94-0 |
| FIRST AID MEASURES | 4.1 Description of first aid measures General advice Consult a physician. Show this safety data sheet to the doctor in attendance. If inhaled If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician. In case of skin contact Wash off with soap and plenty of water. Consult a physician. In case of eye contact Flush eyes with water as a preca ution. If swallowed Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician. 4.2 Most important symptoms and effects, both acute and delayed The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in section 11 4.3 Indication of any immediate medical attention and special treatment needed no data available |
| FIRE-FIGHTING MEASURES | 5.1 Extinguishing media Suitable extinguishing media Use water spray, alcohol - resistant foam, dry chemical or carbon dioxide. 5.2 Special hazards arising from the substance or mixture Carbon oxides, nitrogen oxides (NOx), Sulphur oxides 5.3 Advice for firefighters Wear self contained breathing apparatus for fire fighting if necessary. 5.4 Further information no data available |
| ACCIDENTAL RELEASE MEASURES | 6.1 Personal precautions, protective equipment and emergency procedures Use personal protective equipment. Avoid dust formation. Avoid breathing vapours, mist or gas. Ensure adequate ventilation. Evacuate personnel to safe areas. Avoid breathing dust. For pers onal protection see section 8. 6.2 Environmental precautions Prevent further leakage or spillage if safe to do so. Do not let product enter drains. 6.3 Methods and materials for containment and cleaning up Pick up and arrange disposal without creating dust . Sweep up and shovel. Keep in suitable, closed containers for disposal. 6.4 Reference to other sections For disposal see section 13 |
| HANDLING AND STORAGE | 7.1 Precautions for safe handling Avoid formation of dust and aerosols. Avoid exposure - obtain special instructions before use. Provide appropriate exhaust ventilation at places where dust is formed. For precautions see section 2.2. 7.2 Conditions for safe storage, including any incompatibilities Store in cool place. Keep container tightly closed in a dry and well - ventilated plac e. 7.3 Specific end use(s) Apart from the uses mentioned in section 1.2 no other specific uses are stipulated |
| EXPOSURE CONTROLS/PERSONAL PROTECTION | 8.1 Control parameters Components with workplace control parameters 8.2 Exposure controls Appropriate engineering controls Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at the end of workday. Personal protective equipment Eye/face protection Safety glasses with side - shields conforming to EN166 Use equipment for eye protection tested and approved under appropriate government standards such as NIOSH (US) or EN 166(EU). Skin protection Handle with gloves. Gloves must be inspected prior to use. Us e proper glove removal technique (without touching glove's outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after use in accordance with applicable laws and good laboratory practices. Wash and dry hands. Body Protection impervious clothing, The type of protective equipment must be selected according to the concentration and amount of the dangerous substance at the specific workplace. Respiratory protection Where risk assessment shows air - purifying re spirators are appropriate use a full - face particle respirator type N100 (US) or type P3 (EN 143) respirator cartridges as a backup to engineering controls. If the respirator is the sole means of protection, use a full - face supplied air respirator. Use resp irators and components tested and approved under appropriate government standards such as NIOSH (US) or CEN (EU). Control of environmental exposure Prevent further leakage or spillage if safe to do so. Do not let product enter drains. |
| PHYSICAL AND CHEMICAL PROPERTIES | 9.1 Information on basic physical and chemical properties a) Appearance Form : powder b) Odour no data available c) Odour Threshold no data available d) pH no data available e) Melting point/freezing point no data available f) Initial boiling point and boiling range no data available g) Flash point no data available h) Evapouration rate no data available i) Flammability (solid, gas) no data available j) Upper/lower flammability or explosive limits no data available k) Vapour pressure no data available l) Vapour density no data available m) Relative density no data available n) Water solubility no data available o) Partition coefficient: n - octanol/water no data available p) Auto - ignition temperature no data available q) Decomposition temperature no data available r) Viscosity no data available s) Explosive properties no data available t) Oxidizing properties no data available 9.2 Other safety information no data available |
| STABILITY AND REACTIVITY | 10.1 Reactivity no data available 10.2 Chemical stability Stable under recommended storage conditi ons. 10.3 Possibility of hazardous reactions no data available 10.4 Conditions to avoid no data available 10.5 Incompatible materials Strong oxidizing agents 10.6 Hazardous decomposition products Other decomposition products - no data available In the event of fire: see section 5 |
| TOXICOLOGICAL INFORMATION | 11.1 Information on toxicological effects Acute toxicity LD50 Oral - rat - > 4.000 mg/kg LD50 Intravenous - rat - 225 mg/kg LD50 Intramuscular - rat - > 4.000 mg/kg LD50 Subcutaneous - rabbit - > 3 g/kg LD50 Intravenous - rabbit - 550 mg/kg LD50 Intramuscular - rabbit - > 3 g/kg LD50 Intraperitoneal - mouse - 1.353 mg/kg LD50 Subcutaneous - mouse - 1.100 mg/kg Remarks : Behavioral:Change in motor activity (specific assay). Lungs, Thorax, or Respiration:Other changes. Nutritional and Gross Metabolic:Changes in:Body temperature decrease. TDLo Intramuscular - rat - female - 4.400 mg/kg TDLo Intramuscular - Child - 390 mg/kg Remarks : Sense Organs and Special Senses (Nose, Eye, Ear, and Taste):Ear:Change in acuity Skin corrosion/irritation no data available Serious eye damage/eye irritation no data available Respiratory or skin sensitisation Prolonged or repeated exposure may cause allergic reactions in certain sensitive individuals. Germ cell mutagenicity no data available Carcinogenicity IARC: No component of this product present at levels greater than or equal to 0.1% is identified as probable, possible or confirmed human carcinogen by IARC. Reproductive toxicity Reproductive toxicity - rat - female - Intramuscular Maternal Effects: Other effects. Specific Developmental Abnormalities: Urogenital system. Reproductive toxicity - rat - female - Subcutaneous Effects on Embryo or Fetus: Fetal death. Specific Developmental Abnormalities: Musculosk eletal system. Reproductive toxicity - guinea pig - female - Intramuscular Specific Developmental Abnormalities: Eye, ear. Presumed human reproductive toxicant Specific target organ toxicity - single exposure no data available Specific target organ toxicity - repeated exposure no data available Aspiration hazard no data available Additional Information RTECS : NZ3225030 To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly i nvestigated. Liver - Irregularities - Based on Human Evidence |
| ECOLOGICAL INFORMATION | 12.1 Toxicity no data available 12.2 Persistence and degradability no data available 12.3 Bioaccumulative potential no data available 12.4 Mobility in soil no data available 12.5 Results of PBT and vPvB assessment PBT/vPvB assessment not available as chemical safety assessment not required/not conducted 12.6 Other adverse effects no data available |
| DISPOSAL CONSIDERATIONS | 13.1 Waste treatment methods Product Offer surplus and non - recyclable solutions to a licensed disposal company. Dissolve or mix the material with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber. Contaminated packaging Dispose of as unused pr oduct |
| TRANSPORT INFORMATION | 14.1 UN number ADR/RID : - IMDG : - IATA: - 14.2 UN proper shipping name ADR/RID : Not dangerous goods IMDG : Not dangerous goods IATA: Not dangerous goods 14.3 Transport hazard class(es) ADR/RID : - IMDG : - IATA: - 14.4 Packaging group ADR/RID : - IMDG : - IATA: - 14.5 Environmental hazards ADR/RID : no IMDG Marine pollutant : no IATA: no 14.6 Special precautions for user no data available |
| REGULATORY INFORMATION | This safety datasheet com plies with the requirements of Regulation (EC) No. 1907/2006. 15.1 Safety, health and environmental regulations/legislation specific for the substance or mixture no data available 15.2 Chemical Safety Assessment For this product a chemical safety assessment was not carried out |
| OTHER INFORMATION | The above information is believed to be correct but does not purport to be all inclusive and shall be used only as a guide. The information in this document is based on the present state of our knowledge and is applicable to the product with regard to appropriate safety precautions. It does not represent any guarantee of the properties of the product. For lab use only! |